Shop some of our faves
SHOP PRODUCTSInternational Header
Forbes: La vacuna contra la enfermedad de Lyme podría estar lista en 4 ó 5 años
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Forbes: La vacuna contra la enfermedad de Lyme podría estar lista en 4 ó 5 años
Last updated:
September 16, 2021
| 5 min read
YouTube video highlight
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Read more about the projectForbes: La vacuna contra la enfermedad de Lyme podría estar lista en 4 ó 5 años
No se han encontrado artículos.
No se han encontrado artículos.
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Lyme disease is one of the fastest growing diseases in the northern hemisphere and this week’s announcement that pop star Justin Beiber had the diagnosis brought the tick-borne illness to the forefront of the news. For now, the main prevention lies in avoiding tick contact but one company, Valneva, is working fervently to develop what they believe will be the world’s first vaccine against Lyme’s disease.
Valneva’s has made a name for itself by developing vaccines for in-demand illnesses and now the biotech company has its eyes set on Lyme disease. Their Lyme disease vaccine prototype, VLA15 is currently in Phase 2 developments and is being tested on more than 800 people to measure both efficacy and safety. Although difficult to predict, Valneva’s CEO, Thomas Lingelbach told Forbes that he expected the vaccine to be completed in the next few years.
“Phase 2 will end in the middle of 2020. We expect this will enable us to enter the last clinical phase in mid-2021,” explained Lingelbach. “Depending on those results, we may be four to four and a half years away from the first potential Lyme disease vaccine.”
When completed, the vaccine will likely be administered in three doses, each a month apart. The initial vaccine is expected to last 6 seasons, referring to the time from spring to late summer when the ticks are active and therefore most likely to transfer the illness to humans. After six seasons, Lingelbach believes that boosters will be required, but will likely be needed to be administered every 2-3 seasons.
Read the full article by Dana Dovey on Forbes' website here.
Forbes
Forbes, the homepage for top business news and analysis, is among the most trusted resources for senior business executives.
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Lyme disease is one of the fastest growing diseases in the northern hemisphere and this week’s announcement that pop star Justin Beiber had the diagnosis brought the tick-borne illness to the forefront of the news. For now, the main prevention lies in avoiding tick contact but one company, Valneva, is working fervently to develop what they believe will be the world’s first vaccine against Lyme’s disease.
Valneva’s has made a name for itself by developing vaccines for in-demand illnesses and now the biotech company has its eyes set on Lyme disease. Their Lyme disease vaccine prototype, VLA15 is currently in Phase 2 developments and is being tested on more than 800 people to measure both efficacy and safety. Although difficult to predict, Valneva’s CEO, Thomas Lingelbach told Forbes that he expected the vaccine to be completed in the next few years.
“Phase 2 will end in the middle of 2020. We expect this will enable us to enter the last clinical phase in mid-2021,” explained Lingelbach. “Depending on those results, we may be four to four and a half years away from the first potential Lyme disease vaccine.”
When completed, the vaccine will likely be administered in three doses, each a month apart. The initial vaccine is expected to last 6 seasons, referring to the time from spring to late summer when the ticks are active and therefore most likely to transfer the illness to humans. After six seasons, Lingelbach believes that boosters will be required, but will likely be needed to be administered every 2-3 seasons.
Read the full article by Dana Dovey on Forbes' website here.
Forbes
Forbes, the homepage for top business news and analysis, is among the most trusted resources for senior business executives.
Lyme Disease Vaccine Could Be Ready In 4 to 5 Years
Lyme disease is one of the fastest growing diseases in the northern hemisphere and this week’s announcement that pop star Justin Beiber had the diagnosis brought the tick-borne illness to the forefront of the news. For now, the main prevention lies in avoiding tick contact but one company, Valneva, is working fervently to develop what they believe will be the world’s first vaccine against Lyme’s disease.
Valneva’s has made a name for itself by developing vaccines for in-demand illnesses and now the biotech company has its eyes set on Lyme disease. Their Lyme disease vaccine prototype, VLA15 is currently in Phase 2 developments and is being tested on more than 800 people to measure both efficacy and safety. Although difficult to predict, Valneva’s CEO, Thomas Lingelbach told Forbes that he expected the vaccine to be completed in the next few years.
“Phase 2 will end in the middle of 2020. We expect this will enable us to enter the last clinical phase in mid-2021,” explained Lingelbach. “Depending on those results, we may be four to four and a half years away from the first potential Lyme disease vaccine.”
When completed, the vaccine will likely be administered in three doses, each a month apart. The initial vaccine is expected to last 6 seasons, referring to the time from spring to late summer when the ticks are active and therefore most likely to transfer the illness to humans. After six seasons, Lingelbach believes that boosters will be required, but will likely be needed to be administered every 2-3 seasons.
Read the full article by Dana Dovey on Forbes' website here.
Forbes
Forbes, the homepage for top business news and analysis, is among the most trusted resources for senior business executives.
Menciones en los medios de comunicación
browse all articlesGarage Grown Gear: 2026 PCT Top Picks!
Read MoreRecent articles
Other categories
You might also like
Menciones en los medios de comunicación
An investment helps provide years of safe drinking water for entire families and schools.
Blueprint Digital
Online Marketing Agnecy
Menciones en los medios de comunicación
You spray [permethrin] on your clothes and gear and it turns them into a barrier bugs don't want to cross.
Consumer Betterment
YouTube Channel
Menciones en los medios de comunicación
The Smartwater bottle’s small opening allows you to screw on filters, such as those from Sawyer.
Mary Andino
Escritor colaborador
Explore All Sawyer has to Offer
Built for the Outdoors
see ALL PRODUCTS
Síguenos en Instagram
Más que una empresa de actividades al aire libre.
@sawyerproducts
Síguenos
From the trail
Conoce a nuestros embajadores. Son expertos en los senderos que adoran la forma en que nuestros productos resisten los elementos y nos deleitan con historias de sus aventuras al siguiente nivel.
meet our ambassadors
